Skip to main content
Yuyu Pharma, Inc. logo

Yuyu Pharma, Inc. — Investor Relations & Filings

Ticker · 000220 ISIN · KR7000220004 KO Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2018-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 000220

About Yuyu Pharma, Inc.

https://www.yuyu.co.kr/

Yuyu Pharma, Inc., established in 1941, is a healthcare company focused on the development, manufacturing, and marketing of pharmaceutical products. The company is committed to creating innovative therapeutics to address healthcare challenges and improve quality of life. Its research and development efforts are concentrated on key therapeutic areas, with a notable emphasis on treatments for central nervous system disorders, including Alzheimer's disease. The company operates through several divisions, including Yuyu Healthcare, which provides pharmaceutical-standard Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) services.

Recent filings

Filing Released Lang Actions
분기보고서 (2018.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Yuyu Pharma (주식회사 유유제약) for the 3rd quarter of the 79th fiscal year (2018). It contains detailed financial data, business operations, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-14 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Yuyu Pharma. It details specific share transactions by company executives and major shareholders, including dates, transaction types (e.g., '장내매수' - open market purchase), and updated ownership percentages. This falls under the category of Director's Dealing (DIRS) as it reports personal share transactions by company directors and executives.
2018-10-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea for reporting insider transactions (director's dealings). The content details the share ownership changes of an executive (Choi In-seok) at Yuyu Pharma. Based on the filing definitions, this corresponds to 'Director's Dealing'.
2018-10-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details changes in share ownership (specifically convertible bonds) by a major shareholder (Moorim Capital) in Yuyu Pharma. This falls under the category of Major Shareholding Notification.
2018-10-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.